Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Your prescriber can select the safest and most effective starting point with a branded product
Md Amin, N
Why the dose schedule cannot be rushed Clinical trial data from the phase 2 NEJM study revealed something critical about dose scheduling
[1] [2] Symptoms that have been described include: Injection site reactions : redness, swelling, itching, or mild bruising at the site of subcutaneous administration consistent with class effects seen with semaglutide and tirzepatide (see eMC SmPCs for Wegovy, Ozempic, and Mounjaro for comparator data) Pruritus or urticaria : patchy or widespread skin itching or redness, which may reflect a hypersensitivity response again consistent with known class effects of GLP-1-based therapies [17] Generalised skin sensitivity : heightened sensitivity to touch, temperature, or pressure beyond the injection site
